Technical Focus in US DMF & European CEP Filings
Global filings involve complex regulatory guidelines with low thresholds for mutagenic impurities, solvents, and physical properties. We assist in compilation to reduce CDE/FDA deficiency letters and expedite review.
- 3.2.S.2 Manufacture: synthesis routes, starting material specifications, and process parameters
- 3.2.S.3 Characterization & Impurities: control strategies for mutagenic impurities and structure proof
- 3.2.S.4 Specification Control: method development and validation database matching ICH Q2
- Deficiency Letter responses: drafting letters for FDA/EDQM and designing analytical backup tests
